LANDINI, IDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.475
EU - Europa 4.062
AS - Asia 2.305
SA - Sud America 233
AF - Africa 49
OC - Oceania 42
Totale 12.166
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.423
PL - Polonia 1.370
RU - Federazione Russa 1.353
SG - Singapore 721
CN - Cina 599
HK - Hong Kong 388
IT - Italia 335
IE - Irlanda 294
SE - Svezia 242
KR - Corea 227
BR - Brasile 194
DE - Germania 140
IN - India 97
VN - Vietnam 90
FI - Finlandia 87
GB - Regno Unito 72
JO - Giordania 66
AU - Australia 40
FR - Francia 40
CA - Canada 33
CH - Svizzera 26
TR - Turchia 26
ID - Indonesia 21
ES - Italia 20
UA - Ucraina 20
AT - Austria 19
JP - Giappone 17
AR - Argentina 16
BE - Belgio 14
CI - Costa d'Avorio 14
ZA - Sudafrica 13
NL - Olanda 12
BD - Bangladesh 10
MX - Messico 10
IQ - Iraq 8
MA - Marocco 8
EC - Ecuador 7
BJ - Benin 5
VE - Venezuela 5
CO - Colombia 4
IL - Israele 4
LT - Lituania 4
PK - Pakistan 4
DK - Danimarca 3
OM - Oman 3
PH - Filippine 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BB - Barbados 2
CL - Cile 2
ET - Etiopia 2
GE - Georgia 2
GR - Grecia 2
IR - Iran 2
JM - Giamaica 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
PY - Paraguay 2
QA - Qatar 2
SA - Arabia Saudita 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GI - Gibilterra 1
GT - Guatemala 1
KE - Kenya 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 12.166
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.369
Warsaw 1.361
Ashburn 555
Singapore 480
Fairfield 445
Chandler 328
Hong Kong 322
Dublin 292
Seattle 225
Seoul 224
Woodbridge 219
Houston 203
Cambridge 202
Beijing 171
Wilmington 163
Hefei 149
Ann Arbor 141
Florence 117
Buffalo 91
Altamura 85
Lawrence 78
Princeton 69
Dallas 68
Los Angeles 59
New York 53
Boston 52
Mumbai 44
Munich 43
Bremen 42
Moscow 42
Melbourne 40
Boardman 39
Shanghai 39
Kent 37
Jacksonville 33
Medford 30
Paris 30
Ho Chi Minh City 28
Falls Church 27
Turku 26
The Dalles 24
Bern 22
Chennai 21
Clifton 21
Chicago 20
Hanoi 20
San Diego 19
Redondo Beach 18
Jakarta 17
Phoenix 17
Vienna 17
London 15
São Paulo 15
Abidjan 14
Brussels 14
Tokyo 14
Toronto 14
Council Bluffs 13
Guangzhou 12
Helsinki 12
Barcelona 11
Hillsboro 11
Izmir 11
Norwalk 11
Bengaluru 10
Dong Ket 10
Johannesburg 10
Pune 10
Stockholm 10
Brooklyn 8
Dearborn 8
Lappeenranta 8
Norwich 8
Mexico City 7
Milan 7
Montreal 7
Orem 7
San Francisco 6
Belo Horizonte 5
Cotonou 5
Laurel 5
Philadelphia 5
Poplar 5
Redwood City 5
Shenzhen 5
Andover 4
Blumenau 4
Casablanca 4
Curitiba 4
Da Nang 4
Dhaka 4
Falkenstein 4
Guayaquil 4
Haiphong 4
Hangzhou 4
Newark 4
Romainville 4
Rome 4
Salt Lake City 4
Tappahannock 4
Totale 8.615
Salva come PNG Salva come JPEG
Nome #
In vitro assessment of antibody-conjugated gold nanorods for systemic injections 327
Proteomic Analysis of Ovarian Cancer Cell Responses to Cytotoxic Gold Compounds 316
Emerging drugs in refractory colorectal cancer 313
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies. 312
Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: Possible aid in chemotherapy induced neuropathy 307
Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: A comparative proteomic study 296
Proteomic analysis of the cytotoxic effects induced by the organogold(III) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication 291
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways. 291
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c.) 288
Druggable Targets in Pancreatic Adenocarcinoma 279
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 247
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 224
Replacement of the Thiosugar of Auranofin with Iodide Enhances the Anticancer Potency in a Mouse Model of Ovarian Cancer 212
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies 211
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 196
Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study. 190
Cellular pharmacology of gemcitabine. 188
Cytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivatives. 186
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 183
Chemistry and Biology of Two Novel Gold(I) Carbene Complexes as Prospective Anticancer Agents 181
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 176
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma 171
Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma 171
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 167
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 166
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 163
Gold(III) complexes with 2-substituted pyridines as experimental anticancer agents: Solution behavior, reactions with model proteins, antiproliferative properties 158
The molecular mechanisms of antimetastatic ruthenium compounds explored through DIGE proteomics 156
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 156
Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis 155
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 152
The clinical role of PIK3CA mutations in colorectal cancer 151
Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression 151
Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs 145
PNN and KCNQ1OT1 can predict the efficacy of adjuvant fluoropyrimidine-based chemotherapy in colorectal cancer patients 145
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer 143
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 141
Size dependent biological profiles of PEGylated gold nanorods 141
Vinorelbine in non-small cell lung cancer: Real-World data from a single institution experience 140
Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand. 139
Structure, solution chemistry, antiproliferative actions and protein binding properties of non-conventional platinum(II) compounds with sulfur and phosphorus donors. 137
Erratum: The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways (Oncology Research 25:9 (1441-1451) DOI: 10.3727/096504017X14926854178616) 135
Pharmacological modulation of protein kinase C for overcoming drug resistance in colorectal cancer. Preliminary results of in vitro studies. 134
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 134
Targeting z-Crystallin by aspirin restores the sensitivity to cisplatin in resistant A2780 ovarian cancer cells 133
Molecular characterization of established human colorectal carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil (5-FU) by different selective schedules 132
Pharmacological strategies for overcoming multidrug resistance. 132
Role of ATP-binding cassette transporters in cancer initiation and progression 132
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 130
Synthesis, Structural Characterization, Solution Behavior, and in Vitro Antiproliferative Properties of a Series of Gold Complexes with 2-(2'-Pyridyl)benzimidazole as Ligand: Comparisons of Gold(III) versus Gold(I) and Mononuclear versus Binuclear Derivatives 130
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphysms in primary colorectal cancer patients. 128
Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma 128
Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy 127
Cyclodextrin Inclusion Complexes of Auranofin and Its Iodido Analog: A Chemical and Biological Study 124
In vitro cell growth inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on human tumor cell lines with defective DNA damage response pathways 122
In vitro antiproliferative activity against human colon cancer cell lines of representative 4-thiazolidinones. Part I. 122
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 121
In vitro study on the safety of near infrared laser therapy in its potential application as postmastectomy lymphedema treatment 120
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 119
Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers 114
Comparative genomic hybridization study of genetic changes associated with 5-fluorouracil resistance in HCT-8 colon cancer cell lines: correlations with the expression profiles 111
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines 111
Pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B cell lymphoma: preliminary results 109
Thymidylate Synthase (TS) mRNA expression and TS gene promoter polymorphism in primary colorectal cancer (CRC) patients (PTS) receiving post-operative fluorouracil (5-FU)-based chemotherapy (CT) 107
Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge 107
Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties 106
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 105
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles 102
P118 A preliminary study for evaluation of cannabis - chemotherapy interactions on human colon cancer cells 92
Effects of reduced extracellular sodium on proliferation and invasive activity of renal cell carcinoma cell lines 89
Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients 86
Therapeutic drug monitoring for the cancer patient: challenges and opportunities 77
Sequence-dependent interactions between oxaliplatin (OHP) and 5-fluorouracil (5-FU) in human colon carcinoma cell lines 70
Preliminary characterization of methotrexate (MTX) resistance mechanisms in human colon carcinoma cells DLD-1 70
Preliminary characterization of methotrexate (MTX) resistance mechanisms in human colon carcinoma cells DLD-1 69
Multiple mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 69
Sequence-dependent interactions between oxaliplatin and 5-fluorouracil in human colon carcinoma cell lines 64
Multiple mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1. 57
Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs 28
null 2
Totale 12.310
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.012
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.012
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021509 0 0 0 0 0 95 58 57 77 131 49 42
2021/2022511 13 40 39 17 22 28 36 48 30 17 91 130
2022/20231.480 111 265 68 141 114 262 174 84 174 7 31 49
2023/2024617 21 55 79 16 32 67 82 157 15 21 43 29
2024/20253.818 135 361 242 591 1.092 573 48 176 198 97 144 161
2025/20262.370 532 552 391 335 542 18 0 0 0 0 0 0
Totale 12.310